This article appeared in the October 2014 ASX Investor Update email newsletter. To subscribe to this newsletter please register with the MyASX section or visit the About MyASX page for past editions and more details.
Here is a snapshot of entities that had applied for admission to the official list of ASX, as at October 7, 2014. Upcoming floats has more information, and Recent floats and listings provides information on entities that have listed on ASX in the previous two months. Note: information about upcoming floats can change quickly if companies close their IPO ahead of schedule, or decide to extend their offer. Check the ASX website or talk to your financial adviser for latest information. IPO listing and closing dates are indicative only.
It is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company's lead product, Detach, is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called "super bugs" that make infectious diseases harder to treat. Capital to be raised: $7 million.
Ascend is a clinical-stage company developing innovative cancer treatments. It identifies disease settings where targeting the disease microenvironment or specific cell types can improve clinical outcomes. Its first product, ASN-002, is a treatment designed for direct delivery into tumours and its clinical program will focus on basal cell carcinoma, which is the most common form of skin cancer worldwide. Capital to be raised: $11 million.
A listed investment company that will manage a portfolio of investments in ASX-listed companies. Capital to be raised: $50 million.
A provider of e-commerce enabling and operation outsourcing services. e-Cargo offers a range of services, from fulfilment to operating online sales channels, warehousing, customer delivery, and marketing expertise. Capital to be raised: $40 million.
The company has been established to provide investors with access to a global equity portfolio with a distinctly contrarian high-conviction investment strategy. Capital to be raised: $75 million.
The fund is a newly established Australian real estate investment trust which offers investors an exposure to a quality portfolio of six A-grade metropolitan and business park office properties located across Sydney, Melbourne and Brisbane. Capital to be raised: $255 million.
A listed investment company that aims to outperform the S&P/ASX Small Ordinaries Accumulation Index over the medium to long term, and seeks to provide shareholders with an expected dividend yield of at least 4 per cent per annum, franked to the maximum extent possible. Capital to be raised: $50 million.
The group is a leading integrated supply chain manager of wholesale and retail petrochemical products in China. Capital to be raised: $10 million.
UIL Energy has assembled a portfolio of prospective early-stage conventional and unconventional oil and gas exploration permits in Western Australia and is looking to expand the current portfolio by targeting opportunities within Australia. Capital to be raised: $4.2 million.
The entities listed above have made application for admission to the official list of ASX. Part of this application process includes the allocation of a provisional ASX code and the provision of details about the entity on the linked page below. In some instances ASX provides a link to a third-party site from which the offer document and application form may also be available for download.
The allocation of a code and the provision of a link to a third-party site does not in any way imply that the entity's application for admission to the official list will be approved and should not be considered in any way as an indication of the merits of the entity. Use of a link to a third-party site indicates your acceptance of the conditions.
It is advisable to obtain investment advice before making any investment decisions relying on information provided on a third-party site, and the entity's offer document should be read in its entirety before any decision is made to invest in the entity's securities.
© Copyright 2017 ASX Limited ABN 98 008 624 691. All rights reserved 2017.